|
|
|
The efficacy of FarrowSure® GOLD B was established in a series of immunogenicity studies that demonstrated:
• Serological non-inferiority in swine of the PPV, L bratislava, and L. hardjo fractions compared with the same fractions of the predecessor product FarrowSure® B. 4,5
• Potency of the L. canicola, L. grippotyphosa, L. icterohaemorrhagiae and L. pomona fractions evaluated by codified assays.4,5
• Duration of immunity with the erysipelas fraction that extended out to 18 weeks after administration of the second dose.6 The longest erysipelas DOI currently on the market.
• Producers can expect the same reliable and dependable levels of protection against parvovirus, erysipelas, and leptospirosis using 2-mL FarrowSure® GOLD and FarrowSure® GOLD B. You can count on it.
|
|